Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Hepatitis C, Chronic

quinazolines has been researched along with Hepatitis C, Chronic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, JS; Chen, KY; Chih-Hsin Yang, J; Ho, CC; Liao, WY; Lin, CC; Lin, ZZ; Shih, JY; Yao, ZH; Yu, CJ1
Bardou-Jacquet, E; Guyader, D; Lorho, R1
Binetti, P; La Cesa, A; Massacesi, C; Picardi, A; Santini, D; Tonini, G; Vincenzi, B1
Hanajiri, K; Maruyama, T; Mitsui, H; Nakajima, J; Omata, M1

Other Studies

4 other study(ies) available for quinazolines and Hepatitis C, Chronic

ArticleYear
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
    The oncologist, 2017, Volume: 22, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; ErbB Receptors; Female; Gain of Function Mutation; Gefitinib; Hepatitis C, Chronic; Humans; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Quinazolines; Retrospective Studies; Smoking; Taiwan

2017
Kinase inhibitors in the treatment of chronic hepatitis C virus.
    Gut, 2011, Volume: 60, Issue:6

    Topics: Adult; Antiviral Agents; Erlotinib Hydrochloride; Fatal Outcome; Follow-Up Studies; Hepatitis C, Chronic; Humans; Liver Transplantation; Male; Protein Kinase Inhibitors; Quinazolines

2011
Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient.
    Cancer investigation, 2003, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chemical and Drug Induced Liver Injury; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Enzyme Inhibitors; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Function Tests; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Thiophenes; Viremia

2003
Clinical efficacy and toxiciy of gefitinib in patients with lung cancer.
    Lancet (London, England), 2003, Jun-07, Volume: 361, Issue:9373

    Topics: Aged; Antineoplastic Agents; Ascites; Carcinoma, Non-Small-Cell Lung; Gefitinib; Hepatitis C, Chronic; Humans; Hypoalbuminemia; Liver Cirrhosis; Lung Diseases, Interstitial; Lung Neoplasms; Male; Quinazolines

2003